Literature DB >> 5967371

The inhibition of neuraminidase and antiviral action.

J D Edmond, R G Johnston, D Kidd, H J Rylance, R G Sommerville.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5967371      PMCID： PMC1510828          DOI： 10.1111/j.1476-5381.1966.tb01673.x

Source DB:  PubMed          Journal:  Br J Pharmacol Chemother        ISSN： 0366-0826


× No keyword cloud information.
  12 in total

1.  NEW ANTIVIRAL COMPOUNDS WITH CONSIDERABLE ACTIVITY IN VIVO. IV. AROMATIC ALPHA-KETO ALDEHYDES.

Authors:  G CAVALLINI
Journal:  J Med Chem       Date:  1964-05       Impact factor: 7.446

2.  ANTIVIRAL ACTIVITY OF GLYOXALS AND DERIVATIVES.

Authors:  E L ANDERSON; J E CASEY; M EMAS; E E FORCE; E M JENSEN; R S MATZ; D E RIVARD
Journal:  J Med Chem       Date:  1963-11       Impact factor: 7.446

3.  INHIBITION OF N-ACETYLNEURAMINIC ACID ALDOLASE BY 3-FLUOROSIALIC ACID.

Authors:  R GANTT; S MILLNER; S B BINKLEY
Journal:  Biochemistry       Date:  1964-12       Impact factor: 3.162

4.  THE NEURAMINIDASES AND THEIR ACTION ON GLYCOPROTEINS AND OTHER SIALIC ACID-CONTAINING COMPOUNDS.

Authors:  M E RAFELSON
Journal:  Expos Annu Biochim Med       Date:  1963

5.  Influenza virus sialidase.

Authors:  C HOWE; L T LEE; H M ROSE
Journal:  Nature       Date:  1960-10-15       Impact factor: 49.962

6.  Neuraminidase; its substrate and mode of action.

Authors:  A GOTTSCHALK
Journal:  Adv Enzymol Relat Subj Biochem       Date:  1958

7.  Studies on the neuraminidase of influenza virus. I. Separation and some properties of the enzyme from Asian and PR8 strains.

Authors:  L W MAYRON; B ROBERT; R J WINZLER; M E RAFELSON
Journal:  Arch Biochem Biophys       Date:  1961-03       Impact factor: 4.013

8.  A study of the liberation of orthophosphate from adenosine triphosphate by the stromata of human erythrocytes.

Authors:  E HERBERT
Journal:  J Cell Comp Physiol       Date:  1956-02

9.  Agents with high activity against type 2 poliovirus.

Authors:  D G O'SULLIVAN; P W SA DLER
Journal:  Nature       Date:  1961-10-28       Impact factor: 49.962

10.  The structure-activity relationships of the antiviral chemotherapeutic activity of isatin beta-thiosemicarbazone.

Authors:  D J BAUER; P W SADLER
Journal:  Br J Pharmacol Chemother       Date:  1960-03
View more
  11 in total

1.  Rat liver microsomal and lysosomal beta-glucuronidases differ in both carbohydrate and amino acid compositions.

Authors:  D R Tulsiani; H Six; O Touster
Journal:  Proc Natl Acad Sci U S A       Date:  1978-07       Impact factor: 11.205

2.  Group B streptococcal neuraminidase is actually a hyaluronidase.

Authors:  D G Pritchard; B Lin
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

3.  Heterogeneity of lysosomes originating from rat liver parenchymal cells. Metabolic relationship of subpopulations separated by density-gradient centrifugation.

Authors:  H Pertoft; B Wärmegård; M Höök
Journal:  Biochem J       Date:  1978-07-15       Impact factor: 3.857

4.  Influenza A Virus Neuraminidase Inhibitors.

Authors:  Nongluk Sriwilaijaroen; Christopher J Vavricka; Hiromasa Kiyota; Yasuo Suzuki
Journal:  Methods Mol Biol       Date:  2022

5.  Autolysis of glycoproteins in rat kidney lysosomes in vitro. Effects on the isoelectric focusing behaviour of glycoproteins, arylsulphatase and beta-glucuronidase.

Authors:  A Goldstone; H Koenig
Journal:  Biochem J       Date:  1974-08       Impact factor: 3.857

6.  Studies on human thyroxine-binding globulin. VI. The nature of slow thyroxine-binding globulin.

Authors:  J S Marshall; J Pensky; A M Green
Journal:  J Clin Invest       Date:  1972-12       Impact factor: 14.808

Review 7.  Influenza virus neuraminidase: structure, antibodies, and inhibitors.

Authors:  P M Colman
Journal:  Protein Sci       Date:  1994-10       Impact factor: 6.725

8.  A gene apparently determining the extent of sialylation of lysosomal alpha-mannosidase in mouse liver.

Authors:  M Dizik; R W Elliott
Journal:  Biochem Genet       Date:  1977-02       Impact factor: 1.890

Review 9.  Drug resistance in influenza A virus: the epidemiology and management.

Authors:  Mazhar Hussain; Henry D Galvin; Tatt Y Haw; Ashley N Nutsford; Matloob Husain
Journal:  Infect Drug Resist       Date:  2017-04-20       Impact factor: 4.003

10.  Synthesis, inhibitory activity and oral dosing formulation of AV5124, the structural analogue of influenza virus endonuclease inhibitor baloxavir.

Authors:  Andrei A Ivashchenko; Oleg D Mitkin; Jeremy C Jones; Alexander V Nikitin; Angela G Koryakova; Ruben N Karapetian; Dmitry V Kravchenko; Stephan V Mochalov; Alexey A Ryakhovskiy; Vladimir Aladinskiy; Irina A Leneva; Irina N Falynskova; Ekaterina A Glubokova; Elena A Govorkova; Alexandre V Ivachtchenko
Journal:  J Antimicrob Chemother       Date:  2021-03-12       Impact factor: 5.790
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.